Information updates

COVID-19, allergy and asthma

With widespread cases of COVID-19 in Australia and New Zealand, treating allergic rhinitis (hay fever) and/or asthma regularly and correctly is important for the following reasons:

  • To avoid hay fever and/or asthma symptoms being mistaken for symptoms due to respiratory infections, including COVID-19. 

  • To maintain good health by ensuring that hay fever and/or asthma are well controlled, using nasal sprays, inhalers and other medications as prescribed and directed by the treating doctor.  

  • To reduce coughing and sneezing, which can spread respiratory infections (such as COVID-19, colds and influenza).

If a person's hay fever and/or asthma symptoms occur, despite treatments being used regularly and correctly, and their most recent COVID-19 rapid antigen test result is negative (based on testing at least 1-2 times each week, in regions where tests are readily available), they should:

  • Be allowed to attend their school, early children's education/care centre, other institution or workplace; and 
  • See their doctor as soon as possible to check if their hay fever and/or asthma treatments need to be modified. 

Further information:

www.allergy.org.au/patients/allergic-rhinitis-hay-fever-and-sinusitis

www.allergy.org.au/members/covid-19

 

This news item was issued on 3 February 2022 and updated on 28 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.